396 related articles for article (PubMed ID: 21812752)
1. Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration.
Wen Z; Yan Z; He R; Pang Z; Guo L; Qian Y; Jiang X; Fang L
Drug Deliv; 2011 Nov; 18(8):555-61. PubMed ID: 21812752
[TBL] [Abstract][Full Text] [Related]
2. Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration.
Wen Z; Yan Z; Hu K; Pang Z; Cheng X; Guo L; Zhang Q; Jiang X; Fang L; Lai R
J Control Release; 2011 Apr; 151(2):131-8. PubMed ID: 21362449
[TBL] [Abstract][Full Text] [Related]
3. Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations.
Chen J; Zhang C; Liu Q; Shao X; Feng C; Shen Y; Zhang Q; Jiang X
J Drug Target; 2012 Feb; 20(2):174-84. PubMed ID: 21992548
[TBL] [Abstract][Full Text] [Related]
4. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration.
Gao X; Tao W; Lu W; Zhang Q; Zhang Y; Jiang X; Fu S
Biomaterials; 2006 Jun; 27(18):3482-90. PubMed ID: 16510178
[TBL] [Abstract][Full Text] [Related]
5. A novel small Odorranalectin-bearing cubosomes: preparation, brain delivery and pharmacodynamic study on amyloid-β₂₅₋₃₅-treated rats following intranasal administration.
Wu H; Li J; Zhang Q; Yan X; Guo L; Gao X; Qiu M; Jiang X; Lai R; Chen H
Eur J Pharm Biopharm; 2012 Feb; 80(2):368-78. PubMed ID: 22061263
[TBL] [Abstract][Full Text] [Related]
6. Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration.
Xia H; Gao X; Gu G; Liu Z; Zeng N; Hu Q; Song Q; Yao L; Pang Z; Jiang X; Chen J; Chen H
Biomaterials; 2011 Dec; 32(36):9888-98. PubMed ID: 21937105
[TBL] [Abstract][Full Text] [Related]
7. UEA I-bearing nanoparticles for brain delivery following intranasal administration.
Gao X; Chen J; Tao W; Zhu J; Zhang Q; Chen H; Jiang X
Int J Pharm; 2007 Aug; 340(1-2):207-15. PubMed ID: 17499948
[TBL] [Abstract][Full Text] [Related]
8. Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease.
Hu K; Shi Y; Jiang W; Han J; Huang S; Jiang X
Int J Pharm; 2011 Aug; 415(1-2):273-83. PubMed ID: 21651967
[TBL] [Abstract][Full Text] [Related]
9. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration.
Gao X; Wu B; Zhang Q; Chen J; Zhu J; Zhang W; Rong Z; Chen H; Jiang X
J Control Release; 2007 Aug; 121(3):156-67. PubMed ID: 17628165
[TBL] [Abstract][Full Text] [Related]
10. Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease.
Zhang C; Chen J; Feng C; Shao X; Liu Q; Zhang Q; Pang Z; Jiang X
Int J Pharm; 2014 Jan; 461(1-2):192-202. PubMed ID: 24300213
[TBL] [Abstract][Full Text] [Related]
11. Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration.
Liu Z; Jiang M; Kang T; Miao D; Gu G; Song Q; Yao L; Hu Q; Tu Y; Pang Z; Chen H; Jiang X; Gao X; Chen J
Biomaterials; 2013 May; 34(15):3870-81. PubMed ID: 23453061
[TBL] [Abstract][Full Text] [Related]
12. Odorranalectin modified PEG-PLGA/PEG-PBLG curcumin-loaded nanoparticle for intranasal administration.
Li X; Su J; Kamal Z; Guo P; Wu X; Lu L; Wu H; Qiu M
Drug Dev Ind Pharm; 2020 Jun; 46(6):899-909. PubMed ID: 32375569
[TBL] [Abstract][Full Text] [Related]
13. Concanavalin A-conjugated poly(ethylene glycol)-poly(lactic acid) nanoparticles for intranasal drug delivery to the cervical lymph nodes.
Shao X; Liu Q; Zhang C; Zheng X; Chen J; Zha Y; Qian Y; Zhang X; Zhang Q; Jiang X
J Microencapsul; 2013; 30(8):780-6. PubMed ID: 23631383
[TBL] [Abstract][Full Text] [Related]
14. Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration.
Tahara K; Miyazaki Y; Kawashima Y; Kreuter J; Yamamoto H
Eur J Pharm Biopharm; 2011 Jan; 77(1):84-8. PubMed ID: 21074612
[TBL] [Abstract][Full Text] [Related]
15. Nose-To-Brain Delivery of PLGA-Diazepam Nanoparticles.
Sharma D; Sharma RK; Sharma N; Gabrani R; Sharma SK; Ali J; Dang S
AAPS PharmSciTech; 2015 Oct; 16(5):1108-21. PubMed ID: 25698083
[TBL] [Abstract][Full Text] [Related]
16. In vivo toxicity and immunogenicity of wheat germ agglutinin conjugated poly(ethylene glycol)-poly(lactic acid) nanoparticles for intranasal delivery to the brain.
Liu Q; Shao X; Chen J; Shen Y; Feng C; Gao X; Zhao Y; Li J; Zhang Q; Jiang X
Toxicol Appl Pharmacol; 2011 Feb; 251(1):79-84. PubMed ID: 21163285
[TBL] [Abstract][Full Text] [Related]
17. A tissue factor targeted nanomedical system for thrombi-specific drug delivery.
Shi W; Mei H; Deng J; Chen C; Wang H; Guo T; Zhang B; Li L; Pang Z; Jiang X; Shen S; Hu Y
Biomaterials; 2012 Oct; 33(30):7643-54. PubMed ID: 22819496
[TBL] [Abstract][Full Text] [Related]
18. Brain delivery and systemic effect of cationic albumin conjugated PLGA nanoparticles.
Xu F; Lu W; Wu H; Fan L; Gao X; Jiang X
J Drug Target; 2009 Jul; 17(6):423-34. PubMed ID: 19527113
[TBL] [Abstract][Full Text] [Related]
19. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of glutathione-conjugated albumin nanoparticles for improved brain delivery of hydrophilic fluorescent marker.
Patel PJ; Acharya NS; Acharya SR
Drug Deliv; 2013; 20(3-4):143-55. PubMed ID: 23734981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
